Genhong Cheng Selected Research

Bacterial Pneumonia

1/2012	Poly I:C enhances susceptibility to secondary pulmonary infections by gram-positive bacteria.
7/2009	Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Genhong Cheng Research Topics

Disease

35	Infections 04/2022 - 08/2003
27	Virus Diseases (Viral Diseases) 05/2022 - 06/2004
16	Neoplasms (Cancer) 01/2022 - 08/2003
13	Inflammation (Inflammations) 03/2022 - 12/2004
9	COVID-19 05/2022 - 01/2020
8	Bacterial Infections (Bacterial Infection) 06/2022 - 01/2004
8	Zika Virus Infection 06/2021 - 01/2017
6	Human Influenza (Influenza) 11/2020 - 07/2009
6	Bites and Stings (Sting) 01/2019 - 06/2012
4	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022 - 12/2007
4	Microcephaly 09/2019 - 01/2017
4	Leprosy (Hansen's Disease) 10/2015 - 12/2007
3	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2022 - 01/2017
3	Colitis 07/2013 - 01/2011
3	Reperfusion Injury 07/2013 - 08/2005
3	Vesicular Stomatitis 03/2012 - 01/2006
3	Autoimmune Diseases (Autoimmune Disease) 12/2010 - 01/2008
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 04/2022 - 07/2021
2	Chronic Hepatitis B 01/2022 - 03/2018
2	Malaria 08/2020 - 01/2020
2	Pneumonia (Pneumonitis) 11/2019 - 10/2017
2	Persistent Infection 11/2015 - 04/2013
2	Ischemia 07/2013 - 04/2008
2	Bacterial Pneumonia 01/2012 - 07/2009
2	Melanoma (Melanoma, Malignant) 01/2011 - 02/2009
2	Prostatic Neoplasms (Prostate Cancer) 04/2010 - 06/2004
2	Metabolic Diseases (Metabolic Disease) 08/2007 - 11/2006
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Memory Disorders (Memory Loss) 09/2021

Drug/Important Bio-Agent (IBA)

31	Interferon Type IIBA 04/2022 - 06/2004
25	Antiviral Agents (Antivirals)IBA 05/2022 - 07/2006
17	InterferonsIBA 05/2022 - 01/2006
13	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2007
13	CytokinesIBA 08/2020 - 02/2005
9	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2011 - 08/2003
8	Pharmaceutical PreparationsIBA 01/2022 - 01/2005
6	Interleukin-10 (Interleukin 10)IBA 08/2020 - 12/2007
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2011
5	Pattern Recognition ReceptorsIBA 01/2022 - 12/2007
5	LigandsIBA 01/2019 - 06/2004
5	NF-kappa B (NF-kB)IBA 09/2010 - 08/2003
4	Transcription Factors (Transcription Factor)IBA 12/2021 - 12/2012
4	AntigensIBA 01/2019 - 08/2005
4	LipopolysaccharidesIBA 01/2018 - 08/2004
4	TNF Receptor-Associated Factor 3IBA 01/2018 - 01/2006
3	Monoclonal AntibodiesIBA 05/2022 - 01/2005
3	ChemokinesIBA 03/2022 - 07/2011
3	25-hydroxycholesterolIBA 10/2021 - 01/2017
3	Drug CombinationsIBA 01/2020 - 01/2012
3	VaccinesIBA 10/2018 - 01/2017
3	Interleukin-17 (Interleukin 17)IBA 10/2017 - 05/2008
3	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2016 - 12/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 06/2004
3	Toll-Like Receptor 4IBA 07/2013 - 08/2005
3	Vitamin D FDA LinkGeneric 03/2013 - 10/2009
3	Viral RNAIBA 10/2012 - 02/2009
2	HMGB1 Protein (HMG1)IBA 01/2022 - 07/2013
2	Peptides (Polypeptides)IBA 07/2021 - 11/2020
2	Neutralizing AntibodiesIBA 01/2021 - 06/2012
2	Chloroquine (Aralen)FDA LinkGeneric 01/2020 - 10/2017
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2020 - 09/2019
2	Interleukin-8 (Interleukin 8)IBA 01/2020 - 12/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 12/2007
2	Ribavirin (Virazole)FDA LinkGeneric 11/2019 - 01/2012
2	Interferon-gamma (Interferon, gamma)IBA 01/2019 - 03/2013
2	Amino Acids FDA Link 10/2018 - 07/2006
2	Viral ProteinsIBA 01/2018 - 11/2015
2	AntioxidantsIBA 01/2016 - 08/2005
2	Interleukin-27 (Interleukin 27)IBA 10/2015 - 05/2008
2	bis(3',5')-cyclic diguanylic acidIBA 12/2012 - 06/2012
2	Phosphotransferases (Kinase)IBA 12/2012 - 06/2012
2	Small Interfering RNA (siRNA)IBA 12/2012 - 12/2007
2	DNA VaccinesIBA 06/2012 - 10/2011
2	A-Form DNA (A-DNA)IBA 03/2012 - 02/2009
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2011 - 02/2009
1	CathepsinsIBA 06/2022
1	histone deacetylase 3IBA 06/2022
1	PalmitatesIBA 04/2022
1	Capsules (Microcapsules)IBA 03/2022
1	Butyrates (Butyrate)IBA 03/2022
1	Biological ProductsIBA 03/2022
1	Imiquimod (Aldara)FDA LinkGeneric 03/2022
1	WithanolidesIBA 03/2022
1	Anesthetics (Anesthetic Agents)IBA 03/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Interferon-alpha (Interferon Alfa)IBA 01/2022
1	CyclinsIBA 01/2022
1	CalreticulinIBA 01/2022
1	KynurenineIBA 01/2022
1	talimogene laherparepvecIBA 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022
1	Hemin (Panhematin)FDA Link 01/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022
1	Clomiphene (Clomifene)FDA LinkGeneric 12/2021
1	Tamoxifen FDA LinkGeneric 12/2021

Therapy/Procedure

5	Therapeutics 10/2017 - 04/2010
3	Immunotherapy 12/2021 - 04/2010
3	Radiotherapy 01/2019 - 01/2015
1	Anesthesia 03/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2021